GlaxoSmithKline plc (LSE:GSK) has an ERP5 rank of 5816. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. It looks at the stock’s Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The lower the rank, the more undervalued a company is considered to be.

Although the investing process is fairly straightforward, securing consistent returns in the stock market is not easy. Throwing hard earned money at un-researched investments can eventually lead the investor down the road to ruin. Every individual investor may have different goals when starting out. Aligning these goals with a specific plan can create a solid foundation for the future. Nobody can predict what the future will hold, but being aware of market conditions can be a great asset when attempting to navigate the terrain while mitigating risk. Once the vision of the individual investor is clear, the road to sustaining profits may be much easier to travel.

The Q.i. Value of GlaxoSmithKline plc (LSE:GSK) is 22.00000. The Q.i. Value is another helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be.

**Technicals**

The EBITDA Yield is a great way to determine a company’s profitability. This number is calculated by dividing a company’s earnings before interest, taxes, depreciation and amortization by the company’s enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The EBITDA Yield for GlaxoSmithKline plc (LSE:GSK) is 0.076352.

The Earnings to Price yield of GlaxoSmithKline plc (LSE:GSK) is 0.023951. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the most popular methods investors use to evaluate a company’s financial performance. Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. The Earnings Yield for GlaxoSmithKline plc (LSE:GSK) is 0.068415. Earnings Yield helps investors measure the return on investment for a given company. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. The Earnings Yield Five Year average for GlaxoSmithKline plc is 0.047140.

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of GlaxoSmithKline plc (LSE:GSK) is 0.041142.

**Ratios**

The Current Ratio of GlaxoSmithKline plc (LSE:GSK) is 0.95. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities. A high current ratio indicates that the company might have trouble managing their working capital. A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations.

The Leverage Ratio of GlaxoSmithKline plc (LSE:GSK) is 0.472114. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.

The price to book ratio or market to book ratio for GlaxoSmithKline plc (LSE:GSK) currently stands at 17.368647. The ratio is calculated by dividing the stock price per share by the book value per share. This ratio is used to determine how the market values the equity. A ratio of under 1 typically indicates that the shares are undervalued. A ratio over 1 indicates that the market is willing to pay more for the shares. There are often many underlying factors that come into play with the Price to Book ratio so all additional metrics should be considered as well.

**Adding it All Up**

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of GlaxoSmithKline plc (LSE:GSK) is 6. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. The score is a number between one and one hundred (1 being best and 100 being the worst). The Gross Margin Score of GlaxoSmithKline plc (LSE:GSK) is 25.00000. The more stable the company, the lower the score. If a company is less stable over the course of time, they will have a higher score.

As company earnings reports continue to roll in, investors will be watching to see which companies hit their numbers for the last reporting period. Investors will also be watching which sectors are reporting the best earnings numbers. A positive overall earnings season could mean that the stock market could keep climbing. Many investors may be cautious with the market trading at current levels. Even though the gloom and doom prognosticators are out in full force, investors have to do the research and decide for themselves which way they believe the market will move in the next couple of months.

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Commerzbank AG (DB:CBK) is 9285. The lower the ERP5 rank, the more undervalued a company is thought to be.

When undertaking stock analysis, investors might be searching for companies that are presently undervalued. Undervalued stocks may provide a higher chance of realizing big gains. Finding undervalued stocks that are high quality can be the biggest challenge for the investor. Many investors will dig into the numbers and look for companies that have been consistently making lots of money and performing well on the earnings front.

The Q.i. Value of Commerzbank AG (DB:CBK) is 74.00000. The Q.i. Value is another helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be.

The EBITDA Yield is a great way to determine a company’s profitability. This number is calculated by dividing a company’s earnings before interest, taxes, depreciation and amortization by the company’s enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The EBITDA Yield for Commerzbank AG (DB:CBK) is -20.646066.

The Earnings to Price yield of Commerzbank AG (DB:CBK) is 0.087650. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the most popular methods investors use to evaluate a company’s financial performance. Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. The Earnings Yield for Commerzbank AG (DB:CBK) is 0.016618. Earnings Yield helps investors measure the return on investment for a given company. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. The Earnings Yield Five Year average for Commerzbank AG is 0.011282.

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of Commerzbank AG (DB:CBK) is -0.000890.

**Price Index**

We can now take a quick look at some historical stock price index data. Commerzbank AG (DB:CBK) presently has a 10 month price index of 0.57088. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.64144, the 24 month is 1.18058, and the 36 month is 0.76975. Narrowing in a bit closer, the 5 month price index is 0.94578, the 3 month is 0.91497, and the 1 month is currently 0.96156.

**Returns**

Looking at some ROIC (Return on Invested Capital) numbers, Commerzbank AG (DB:CBK)’s ROIC is 0.005455. The ROIC 5 year average is 0.003460 and the ROIC Quality ratio is -4.192577. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits.

Commerzbank AG (DB:CBK) has a Price to Book ratio of 0.343317. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book to display how the market portrays the value of a stock. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 4.883880, and a current Price to Earnings ratio of 11.409066. The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued.

Commerzbank AG (DB:CBK) presently has a current ratio of 0.00. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Commerzbank AG DB:CBK is 0.343317. A lower price to book ratio indicates that the stock might be undervalued. Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value. The Price to Cash Flow for Commerzbank AG (DB:CBK) is 4.883880. This ratio is calculated by dividing the market value of a company by cash from operating activities. Additionally, the price to earnings ratio is another popular way for analysts and investors to determine a company’s profitability. The price to earnings ratio for Commerzbank AG (DB:CBK) is 11.409066. This ratio is found by taking the current share price and dividing by earnings per share.

Investors may be looking ahead to the next couple of quarters trying to gauge whether the bulls will stay in charge or if the bears will start to take over. Of course, nobody knows for sure which way the market will turn, but being ready for any situation can greatly help the investor prepare. Many investors will be trying to find that balance between being too aggressive and too conservative with stock selection. This can be a tricky aspect to address as there are so many different factors that can come into play. Studying the important pieces of economic data on a regular basis can help with crafting a legitimate hypothesis about where stocks will be in the future.

**Receive News & Ratings Via Email** - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.